CAP Distributive Model of NGS: A Rapid, Economical Approach to Building Your Clinical NGS Program
Optimism for next generation sequencing (NGS) technologies to be used in a clinical setting quickly turns to numerous conversations about the challenges involved. These challenges range from implementing and validating tests, finding people with expertise, and efficiently and accurately interpreting data from the tests. In our upcoming webinar, we discuss the CAP (College of American Pathologists) Distributive Model and how your organization can leverage it to rapidly and economically conduct or scale clinical NGS testing.
Join us for a webinar on August 28 at 2:00 PM Eastern Time as Karl Voelkerding, MD, FCAP, ARUP Laboratories; Shalini Verma, MD, FCAP, PierianDx; and Rakesh Nagarajan, MD, PhD, PierianDx; discuss the CAP distributive model.
In this webinar, you will:
- Receive an overview of the CAP distributive model and how it can help overcome the barriers inherent in genomic testing
- Understand the CAP accreditation requirements and the responsibilities of the Lab Director when implementing the CAP distributive model
- Learn how to set up a quality management program to ensure beginning-to-end test performance
- See firsthand examples of laboratories that have successfully employed the CAP distributive model